The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups
Open accessAbstract
BACKGROUND: Glycemic variability has been proposed as a contributing factor in the development of diabetes complications. Multiple measures exist to calculate the magnitude of glycemic variability, but normative ranges for subjects without diabetes have not been described. For treatment targets and clinical research we present normative ranges for published measures of glycemic variability. METHODS: Seventy-eight subjects without diabetes having a fasting plasma glucose of <120 mg/dL (6.7 mmol/L) underwent up to 72 h of continuous glucose monitoring (CGM) with a Medtronic Minimed (Northridge, CA) CGMS(®) Gold device. Glycemic variability was calculated using EasyGV(©) software (available free for non-commercial use at www.easygv.co.uk ), a custom program that calculates the SD, M-value, mean amplitude of glycemic excursions (MAGE), average daily risk ratio (ADRR), Lability Index (LI), J-Index, Low Blood Glucose Index (LBGI), High Blood Glucose Index (HBGI), continuous overlapping net glycemic action (CONGA), mean of daily differences (MODD), Glycemic Risk Assessment in Diabetes Equation (GRADE), and mean absolute glucose (MAG). RESULTS: Eight CGM traces were excluded because there were inadequate data. From the remaining 70 traces, normative reference ranges (mean±2 SD) for glycemic variability were calculated: SD, 0-3.0; CONGA, 3.6-5.5; LI, 0.0-4.7; J-Index, 4.7-23.6; LBGI, 0.0-6.9; HBGI, 0.0-7.7; GRADE, 0.0-4.7; MODD, 0.0-3.5; MAGE-CGM, 0.0-2.8; ADDR, 0.0-8.7; M-value, 0.0-12.5; and MAG, 0.5-2.2. CONCLUSIONS: We present normative ranges for measures of glycemic variability in adult subjects without diabetes for use in clinical care and academic research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Service, F. J., Molnar, G. D., Rosevear, J. W., Ackerman, E., Gatewood, L. C., & Taylor, W. F. (1970) · Diabetes · doi:10.2337/diab.19.9.644 · Cited by 1,039
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 769
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Glucose variability is associated with intensive care unit mortality*
Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4be9 · Cited by 437
Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture
Risso, A., Mercuri, F., Quagliaro, L., Damante, G., & Ceriello, A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e924 · Cited by 425
The M‐Value, an Index of Blood‐sugar Control in Diabetics
SCHLICHTKRULL, J., MUNCK, O., & JERSILD, M. (1965) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1965.tb01810.x · Cited by 385
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic Variation
McDonnell, C. M., Donath, S. M., Vidmar, S. I., Werther, G. A., & Cameron, F. J. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.253 · Cited by 358
Ryan, E. A., Shandro, T., Green, K., Paty, B. W., Senior, P. A., Bigam, D., Shapiro, A. M. J., & Vantyghem, M.-C. (2004) · Diabetes · doi:10.2337/diabetes.53.4.955 · Cited by 343
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D., Gonder-Frederick, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 333
Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability
Molnar, G. D., Taylor, W. F., & Ho, M. M. (1972) · Diabetologia · doi:10.1007/bf01218495 · Cited by 272
(1986) · PubMed · Cited by 225
Kilpatrick, E. S., Rigby, A. S., Goode, K., & Atkin, S. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0820-z · Cited by 209
Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes
Wentholt, I. M. E., Kulik, W., Michels, R. P. J., Hoekstra, J. B. L., & DeVries, J. H. (2007) · Diabetologia · doi:10.1007/s00125-007-0842-6 · Cited by 203
Piconi, L., Quagliaro, L., Da Ros, R., Assaloni, R., Giugliano, D., Esposito, K., Szabó, C., & Ceriello, A. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00835.x · Cited by 197
Mazze, R. S., Strock, E., Wesley, D., Borgman, S., Morgan, B., Bergenstal, R., & Cuddihy, R. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0293 · Cited by 182
Schiekofer, S., Andrassy, M., Chen, J., Rudofsky, G., Schneider, J., Wendt, T., Stefan, N., Humpert, P., Fritsche, A., Stumvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.621 · Cited by 180
“J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients
Wójcicki, J. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979906 · Cited by 159
Kovatchev, B. P., Cox, D. J., Kumar, A., Gonder-Frederick, L. A., & Clarke, W. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322527021 · Cited by 157
A method for assessing quality of control from glucose profiles
Hill, N. R., Hindmarsh, P. C., Stevens, R., STRATTON, I. M., Lévy, J., & Matthews, D. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02119.x · Cited by 134
Self-citationValidation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis
O’Riordan, S., Hindmarsh, P. C., Hill, N. R., Matthews, D. R., George, S., Greally, P., Canny, G. J., Slattery, D. M., Murphy, N., Roche, E. F., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1925 · Cited by 103
Self-citationZhou, J., Li, H., Ran, X., Yang, W., Li, Q., Peng, Y., Li, Y., Gao, X., Luan, X., Wang, W., et al. (2011) · Medical Science Monitor · doi:10.12659/msm.881318 · Cited by 88
Wentholt, I. M. E., Hart, A. A. M., Hoekstra, J. B. L., & DeVries, J. H. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0007 · Cited by 54
Continuous glucose monitoring in patients with insulinoma
Munir, A., Choudhary, P., Harrison, B. J., Heller, S. R., & Newell-Price, J. D. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03161.x · Cited by 51
Self-citationMarfella, R., Barbieri, M., Ruggiero, R., Rizzo, M. R., Grella, R., Mozzillo, A. L., Docimo, L., & Paolisso, G. (2009) · Diabetes Care · doi:10.2337/dc09-1343 · Cited by 29
Cited by
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Glycemic variability: adverse clinical outcomes and how to improve it?
Zhou, Z., Sun, B., Huang, S., Zhu, C., & Bian, M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01085-6 · Cited by 255
Sun, B., Luo, Z., & Zhou, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01200-7 · Cited by 168
Metadata
- Authors
- Hill, N. R., Oliver, N. S., Choudhary, P., Levy, J. C., Hindmarsh, P., & Matthews, D. R.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2011-09
- Volume
- 13
- Issue
- 9
- Pages
- 921-928
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2069099947
- Cited by
- 362
- References
- 35
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.